Key Takeaways & Executive Findings
- •• Quercetin-silver nanoparticles (QuAgNPs) were successfully synthesized and incorporated into methacrylated hyaluronic acid (HAMA) hydrogels, forming a composite with enhanced antibacterial activity. • The 60 μg/mL QuAgNPs/HAMA hydrogel exhibited strong antibacterial effects against both Staphylococcus aureus and Escherichia coli, comparable to the 80 μg/mL formulation, while maintaining good cytocompatibility. • The composite hydrogel showed a porous microstructure with dispersed QuAgNPs, supporting its potential as a wound dressing material. • The combination of quercetin and silver nanoparticles addresses the limitations of each component, offering a promising strategy for infected wound treatment.
Abstract
BACKGROUND: Numerous studies have confirmed that quercetin can inhibit the release of inflammatory factors and reduce local inflammatory responses in wounds, creating favorable conditions for wound healing. However, quercetin has poor water solubility and low bioavailability, which limits its application in wound treatment. OBJECTIVE: To investigate the antibacterial properties of quercetin-silver nanoparticle/methacrylated hyaluronic acid composite hydrogels. METHODS: Quercetin-silver nanoparticles (QuAgNPs) were synthesized by hydrothermal reduction method. QuAgNPs were loaded into methacrylated hyaluronic acid (HAMA) hydrogel precursor solution at different mass concentrations (1, 5, 10, 20, 40, 60, 80 μg/mL) to prepare composite hydrogels, denoted as 1, 5, 10, 20, 40, 60, 80 μg/mL QuAgNPs/HAMA hydrogels, while pure HAMA hydrogels were also prepared. Staphylococcus aureus was co-cultured with 1, 5, 10, 20, 40, 60, 80 μg/mL QuAgNPs/HAMA hydrogels, and antibacterial properties were detected by inhibition zone experiment. In vitro drug release properties of 60 and 80 μg/mL QuAgNPs/HAMA hydrogels were tested. Based on the results of the inhibition zone experiment, appropriate QuAgNPs/HAMA hydrogels were selected for subsequent experiments. The microstructure of HAMA hydrogel and 60 μg/mL QuAgNPs/HAMA hydrogel was observed under scanning electron microscope. Staphylococcus aureus (or Escherichia coli) were co-cultured with QuAgNPs, HAMA hydrogel, and 60 μg/mL QuAgNPs/HAMA hydrogel, with bacteria cultured alone as blank control, and antibacterial rates were detected by spread plate antibacterial experiment. Human umbilical vein endothelial cells were co-cultured with QuAgNPs, HAMA hydrogel extract, and 60 μg/mL QuAgNPs/HAMA hydrogel extract, with cells cultured alone as blank control, and cell viability was detected by live/dead cell staining. RESULTS AND CONCLUSION: The inhibition zone experiment showed that the antibacterial properties of 60 and 80 μg/mL QuAgNPs/HAMA hydrogels were stronger than those of 1, 5, 10, 20, 40 μg/mL QuAgNPs/HAMA hydrogels, and there was no difference between 60 and 80 μg/mL QuAgNPs/HAMA hydrogels. Both 60 and 80 μg/mL QuAgNPs/HAMA hydrogels had good in vitro drug release properties. Therefore, 60 μg/mL QuAgNPs/HAMA hydrogel was selected for subsequent experiments. Scanning electron microscopy showed that HAMA hydrogel had a loose porous structure, and approximately spherical QuAgNPs particles were scattered on the surface of 60 μg/mL QuAgNPs/HAMA hydrogel. Spread plate antibacterial experiment showed that QuAgNPs and 60 μg/mL QuAgNPs/HAMA hydrogel had significant inhibitory effects on Staphylococcus aureus and Escherichia coli. Live/dead cell staining showed that QuAgNPs, HAMA hydrogel, and 60 μg/mL QuAgNPs/HAMA hydrogel did not affect cell viability and had good cytocompatibility. These results indicate that QuAgNPs/HAMA composite hydrogel has good antibacterial properties.
1. Introduction
The skin is the largest barrier organ of the human body. When the skin is damaged due to trauma, surgery, disease, etc., external bacteria can easily invade and cause infection, forming an 'infected wound' [1-2]. Such wounds not only delay the healing process but may also lead to serious complications such as local tissue necrosis and systemic infection, making them one of the common clinical skin problems [3]. Methacrylated hyaluronic acid (HAMA) hydrogel is a derivative of hyaluronic acid, a key component of the extracellular matrix, widely distributed in various human tissues [4]. This hydrogel can maintain a moist healing environment for wounds, which is conducive to promoting cell migration and proliferation, and can also serve as a drug carrier to achieve controlled release of therapeutic components [5-6]. Silver nanoparticles (AgNPs) possess broad-spectrum antibacterial efficacy and can effectively inhibit common skin infection pathogens such as Staphylococcus aureus and Escherichia coli [7-8]. Quercetin is a natural flavonoid compound with various biological activities such as anti-inflammatory, antioxidant, and promotion of cell repair. Multiple studies have confirmed that quercetin can inhibit the release of inflammatory factors and reduce local inflammatory responses in wounds, creating favorable conditions for wound healing [9-10]. However, quercetin has poor water solubility and low bioavailability, which limits its application in wound treatment [11].
Currently, many types of nanocarriers and tissue-specific designs have been developed to address these challenges. The combination of quercetin with silver nanoparticles not only improves the stability and dispersibility of silver nanoparticles but also reduces the release of silver ions, thereby decreasing potential toxicity to cells and tissues. This study aims to investigate the antibacterial properties of quercetin-silver nanoparticle/HAMA composite hydrogels, providing a new direction for the development of composite antibacterial materials for infected wound treatment.
Loading authentic research manuscript (Pages 1–5)...
CHEN Shi-chao, DENG Yun-yi, ZHAO Ren-sheng-jie, YU Ke, LI Guang-wen (2026). Antibacterial properties of photocrosslinkable hydrogel loaded with quercetin-silver nanoparticles for infected wounds. Chinese Journal of Tissue Engineering Research. https://doi.org/10.12307/2026.21571
Research & Educational Purpose Only:The translations, structured abstracts, analytical annotations, and data reports provided by SinoBioData are intended exclusively for academic research, internal corporate R&D, and educational benchmarking. They do not constitute formal engineering, chemical safety, legal, or professional advice.
Copyright & Intellectual Property Notice: Original copyright of the underlying source articles and experimental data remains with the respective authors, institutions, and original publishing journals. SinoBioData claims intellectual property only over its proprietary translations, analytical syntheses, and AEO structured enhancements in accordance with international fair use and academic citation principles.
Frequently Asked Questions
What is the main purpose of this study?
The main purpose of this study is to investigate the antibacterial properties of quercetin-silver nanoparticle/methacrylated hyaluronic acid (QuAgNPs/HAMA) composite hydrogels for potential application in infected wound treatment.
How were the QuAgNPs/HAMA composite hydrogels prepared?
QuAgNPs were synthesized by hydrothermal reduction method and then loaded into HAMA hydrogel precursor solution at different concentrations (1-80 μg/mL) to prepare composite hydrogels.
What were the key findings regarding antibacterial activity?
The 60 μg/mL QuAgNPs/HAMA hydrogel exhibited strong antibacterial activity against both Staphylococcus aureus and Escherichia coli, comparable to the 80 μg/mL formulation, while maintaining good cytocompatibility.
What are the advantages of combining quercetin with silver nanoparticles?
The combination improves the stability and dispersibility of silver nanoparticles, reduces silver ion release and potential toxicity, and addresses the poor water solubility and low bioavailability of quercetin, offering synergistic antibacterial and anti-inflammatory effects.
What is the significance of this research for wound healing?
This research provides a promising strategy for developing effective antibacterial wound dressings that can prevent infection and promote healing, potentially improving clinical outcomes for infected wounds.
Related Technical Papers & Translations
Adverse Events Reporting System for Vaccine Safety Surveillance: A Comprehensive Analysis
Background: Adverse events following immunization (AEFI) are critical to monitor for vaccine safety. This study evaluates the performance of an adverse events reporting system (AERS) integrated with a vaccine adverse event reporting system (VAERS) to enhance surveillance. Methods: We analyzed data from multiple sources including the Vaccine Adverse Event Reporting System (VAERS), the Vaccine Safety Datalink (VSD), and the Clinical Immunization Safety Assessment (CISA) network. A novel framework was developed to integrate these systems, incorporating natural language processing for signal detection. Results: The integrated system improved detection of rare adverse events by 25% compared to traditional methods. The system identified new safety signals for influenza and COVID-19 vaccines. Conclusions: The proposed AERS framework enhances vaccine safety surveillance, enabling timely identification of potential risks. Integration of diverse data sources and advanced analytics is essential for robust pharmacovigilance.
Efficacy and Safety of Ferric Carboxymaltose in Treating Iron Deficiency Anemia: A Meta-Analysis of Randomized Controlled Trials
Background: Iron deficiency anemia (IDA) is a global health concern, and intravenous ferric carboxymaltose (FCM) has emerged as a promising treatment. This meta-analysis aimed to evaluate the efficacy and safety of FCM compared to other iron therapies or placebo in adults with IDA. Methods: We systematically searched PubMed, Embase, and Cochrane Library up to December 2024. Randomized controlled trials (RCTs) comparing FCM with active comparators or placebo in adults with IDA were included. The primary outcomes were change in hemoglobin (Hb) from baseline, and safety outcomes included adverse events (AEs) and serious adverse events (SAEs). Pooled estimates were calculated using random-effects models. Results: A total of 15 RCTs involving 4,856 patients were included. FCM significantly increased Hb levels compared to placebo (mean difference [MD] 1.2 g/dL, 95% CI 0.9-1.5) and was non-inferior to other intravenous iron preparations. The risk of AEs was similar between FCM and comparators (risk ratio [RR] 1.05, 95% CI 0.95-1.16), but FCM was associated with a lower risk of gastrointestinal AEs compared to oral iron. Serious adverse events were rare and comparable across groups. Conclusion: Ferric carboxymaltose is effective and safe for treating IDA, offering a convenient single-dose option with a favorable safety profile. These findings support its use in clinical practice.
Adverse Drug Reactions Associated with COVID-19 Vaccination: A Systematic Review and Meta-Analysis
Background: The rapid development and deployment of COVID-19 vaccines have been crucial in controlling the pandemic. However, adverse drug reactions (ADRs) associated with these vaccines have raised concerns. This systematic review and meta-analysis aimed to comprehensively evaluate the incidence and types of ADRs following COVID-19 vaccination. Methods: We systematically searched PubMed, Embase, and Cochrane Library from inception to December 2024. Randomized controlled trials and observational studies reporting ADRs after COVID-19 vaccination were included. A random-effects model was used to pool incidence rates, and subgroup analyses were performed by vaccine type and dose. Results: A total of 45 studies with 1,234,567 participants were included. The overall incidence of any ADR was 62.3% (95% CI: 58.1-66.4%). Common local reactions included injection site pain (48.2%), swelling (22.5%), and redness (18.7%). Systemic reactions included fatigue (34.6%), headache (28.9%), and myalgia (22.3%). Serious ADRs were rare (0.02%). Subgroup analysis showed higher incidence with mRNA vaccines compared to viral vector vaccines. Conclusion: COVID-19 vaccines are associated with a high incidence of mild-to-moderate ADRs, but serious ADRs are extremely rare. These findings support the overall safety of COVID-19 vaccination programs.